June 2012
FDA doubts Sanofi’s new blood thinner
- Fri, 06/22/2012 - 2:21pm
The U.S. Food and Drug Administration questions the advantages of Sanofi’s new blood thinner to cancer patients undergoing chemotherapy.
FDA Reports Metal-on-Metal Hip Implant Statistics
- Fri, 06/22/2012 - 12:54pm
The Food and Drug Administration has concerns regarding metal-on-metal hip implants due to the myriad of negative effects they have had on people in the US in the past decade.
What a difference a day makes: Pradaxa v. Warfarin
- Fri, 06/22/2012 - 11:25am
Man alleges Actos caused bladder cancer in four months’ time
- Tue, 06/19/2012 - 2:20pm
Pradaxa's bleeding concerns
- Mon, 06/18/2012 - 3:26pm
Fentanyl Patch Fatalities
- Mon, 06/18/2012 - 2:24pm
In the past 15 years, 26 children have suffered accidental exposure to fentanyl patches, according to the FDA and the Institute for Safe Medicine Practices.
Pradaxa forces patients to do their homework
- Mon, 06/18/2012 - 12:48pm
Pradaxa is proving to be as problematic as its predecessor, warfarin.
Yaz and your cardiovascular health
- Thu, 06/14/2012 - 3:45pm
Actos' role in blindness and bladder cancer
- Thu, 06/14/2012 - 3:11pm
Recent studies reveal that thiazolidinediones like pioglitazone (Actos) and rosiglitazone (Avandia) pose both an increased